The Briefing Part 1

Chapter 097: The Briefing Part 1 The private elevator to the fortieth floor rejected Catherine Marsh's badge with a soft red flash before David Choi could notice her hand tremble. For half a second Leah saw the failure as a verdict: level two analyst, no executive clearance, no right to stand within twenty feet of Martha Thorne. Then David tapped his own card, pressed his thumb to the biometric plate, and the gate opened for both of them. "Stay close," he said, already walking. Leah stepped through behind him with a briefing folder against her ribs and a heartbeat disciplined into silence. She had not been on this floor since she was seventeen and still believed power was something her family would teach her to use. Now Catherine Marsh was entering as borrowed labor, and Isabella Thorne was entering as a ghost no one could be allowed to see. The fortieth floor had not changed enough. That was the cruelty of it. The same private corridor curved away from the elevator bank. The same mahogany conference-room doors sat under brass number plates. Original art still hung where Martha had once placed it to remind visitors that wealth could afford taste as camouflage. Even the air held the old mix of leather, flowers, and controlled temperature. David stopped outside Conference Room 40-A. "Quick reminder. I present the portfolio overview. You present clinical diagnostics, pages twelve through twenty-four. You answer only what is asked. You do not speculate, you do not volunteer risk language, and you do not make eye contact with Martha for more than two seconds." The instruction struck too close to childhood. Isabella had learned the same rule at dinner tables. "Understood," Catherine said. David opened the door. Martha Thorne sat at the far end of the table in a cream suit and a single strand of pearls, her hands folded as if the room had assembled around them. Antonio Costa sat to her left, heavier than Leah remembered from gala photographs, his mouth tight with the public strain of the Times article and the SEC inquiry. Beside him, a silver-haired Foundation trustee scrolled through a tablet. To Martha's right sat Richard Thorne. Richard. Leah's breath caught so small it became pain. He looked thinner. The broad, patient strength she remembered had been pared down to a dark suit that hung a little wrong and eyes fixed on the table instead of the room. Grief had not made him dramatic. It had made him quiet. Martha had always known how to make people smaller without touching them. David moved to the near end. Leah followed, placed her folder beside his, and sat with Catherine's posture: straight back, neutral face, hands still. She could feel Richard five seats away. She could feel Martha beyond him like a blade laid flat on the table. David began with market size, segment performance, portfolio exposure. He was good, crisp and unembarrassed by tension. Leah listened with half her mind and used the rest to map the room the way Ethan had taught her: who watched the slides, who watched the speaker, who watched the exits. Antonio Costa watched numbers as if they might absolve him. The trustee took notes with professional indifference. Richard kept looking down, but his fingers rested near the edge of a printed packet in the exact position he had once used when waiting to ask Isabella whether she understood a balance sheet footnote. Martha watched everything. Not constantly. That was what made it dangerous. Her attention moved in small, exact doses: David's hands when he changed slides, Antonio's jaw when NexGen appeared in a chart, the trustee's note-taking, the doorway, the water glasses, Leah's face for one measured second and then away again. No recognition. Not yet. The room itself worked against her. Every polished surface reflected a version of Catherine Marsh that Leah had practiced for months, but the walls remembered Isabella. She remembered waiting outside this room at fourteen while Richard argued against a Foundation acquisition Martha wanted. She remembered Martha emerging first, already victorious, and touching Isabella's shoulder with a hand that felt less like affection than possession. That memory tried to rise now, bright and useless. Leah pushed it down until all that remained was the slide number and David's next sentence. "Catherine Marsh will walk us through diagnostics and pharmaceuticals," David said. Leah stood. Her knees did not betray her. She crossed to the screen, lifted the clicker, and let Catherine's voice enter the room before Isabella could. "The clinical diagnostics segment represents approximately twelve percent of Costa Holdings' healthcare portfolio by revenue. Over the past five years, growth has been driven primarily by acquisitions in point-of-care testing and specialty lab services." The first slide was safe. The second was safe. The third showed acquisition timing, revenue contribution, margin pressure. She moved through it with the calm of a woman explaining a model she had built herself. That part was true. Catherine Marsh was a real analyst now, because Leah had made her real one clean spreadsheet at a time. When she reached pharmaceuticals, Antonio Costa stopped adjusting his cuff. "NexGen Therapeutics remains the largest single acquisition in the portfolio," Leah said. "The deal closed at three hundred forty million dollars, with projected FDA approval timing in the fourth quarter of 2024. The current internal model assumes commercial launch within six months of approval, with sensitivity analysis around manufacturing scale-up and trial-data review." Martha's eyes moved from the slide to Leah. Two seconds, David had said. Leah gave her two. No more. She turned back to the screen and continued before the silence could show teeth. "One variance appears across the clinical records. Reported Phase III outcomes and raw patient files differ by approximately three point seven percent. The internal explanation attributes the discrepancy to data-entry inconsistencies in the trial management system." There it was. Sofia's red-marked doubt, stripped of blood and fear, dressed in corporate language and projected ten feet wide for the people who had profited from it. Leah had rehearsed this sentence until it no longer sounded like betrayal. The trick was to present the sanitized ThorneVault version without endorsing it, to let Catherine be technically useful while Isabella kept the real accusation alive underneath. If she overplayed the risk, Martha would ask who had taught a junior analyst to see fraud. If she underplayed it, Antonio would relax too quickly and David would think she had missed the significance. The answer had to sit in the exact gray space where corporate people hid crimes and called them assumptions. Antonio's hand closed around his pen. Richard looked up. Martha did not move. "Ms. Marsh." Leah faced her with a clicker in one hand and a lie sharpened into technical accuracy in the other. "Can you elaborate on that variance?"